Sharkey, Howes & Javer’s Chemours CC Stock Holding History

Sharkey, Howes & Javer’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-600	Closed	-$14K	–	74
2019 Q2	$14K	Hold	600	–	–	0.01%	144
2019 Q1	$22K	Hold	600	–	–	0.01%	136
2018 Q4	$17K	Hold	600	–	–	0.01%	137
2018 Q3	$24K	Hold	600	–	–	0.01%	139
2018 Q2	$27K	Hold	600	–	–	0.02%	127
2018 Q1	$29K	Hold	600	–	–	0.02%	112
2017 Q4	$30K	Hold	600	–	–	0.02%	110
2017 Q3	$33K	Sell	600 -68	-10%	-$3.21K	0.02%	102
2017 Q2	$25K	Hold	668	–	–	0.01%	114
2017 Q1	$26K	Buy	668 +68	+11%	+$2.05K	0.01%	124
2016 Q4	$13K	Buy	+600	New	+$12.3K	0.01%	159

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sharkey, Howes & Javer's CC Position: Q3 2019 in Review

Sharkey, Howes & Javer sold out of Chemours (CC) in Q3 2019, closing a stake of 600 shares — an estimated $14K sold.

Sharkey, Howes & Javer first reported a position in CC in Q4 2016 and held it in 11 quarters. The position peaked at $33K in Q3 2017. 419 funds tracked by Wall St. Rank hold CC as of Q3 2019.

Sharkey, Howes & Javer reported no remaining Chemours position as of Q3 2019 after selling out during the quarter.
Sharkey, Howes & Javer sold 600 Chemours shares in Q3 2019, an estimated $14K.
Sharkey, Howes & Javer first reported a position in Chemours in Q4 2016 and held it in 11 quarters.
Sharkey, Howes & Javer's Chemours position peaked at $33K in Q3 2017.
419 funds tracked by Wall St. Rank held Chemours as of Q3 2019.

Based on Sharkey, Howes & Javer's 13F filing for Q3 2019, filed 1 Nov 2019.